← Back to Search

Minimally Invasive Proximal Gastrectomy/MIPG for Stomach Cancer

N/A
Recruiting
Led By Vivian Strong, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after surgery
Awards & highlights

Study Summary

Participants will a diagnosis of gastroesophageal junction (GEJ) adenocarcinoma and will have either a minimally invasive proximal gastrectomy (MIPG) or a minimally invasive total gastrectomy (MITG) as part of their routine care. Participants with complete a questionnaire 1 month before the surgical procedure and then 1, 3, 6 and 12 months after the surgical procedure.

Eligible Conditions
  • Stomach Cancer
  • Gastroesophageal Cancer
  • Gastroesophageal Junction Adenocarcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Appetite level score according to the MDASI-GI

Trial Design

2Treatment groups
Experimental Treatment
Group I: Minimally Invasive Total Gastrectomy/MITGExperimental Treatment1 Intervention
Participants will undergo MITG (Standard of Care/Control Group)
Group II: Minimally Invasive Proximal Gastrectomy/MIPGExperimental Treatment1 Intervention
Participants will undergo MIPG (Trial Procedure)

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,935 Previous Clinical Trials
588,845 Total Patients Enrolled
Vivian Strong, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
1 Previous Clinical Trials
78 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
2024. "A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06243757.
All > Paid Studies Houston > Paid Studies Pasadena
~7 spots leftby Jan 2036
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top